Homocysteine, Methylenetetrahydrofolate Reductase C677T Polymorphism, and Risk of Retinal Vein Occlusion: A Meta-analysis

Ophthalmology

Volumn 116, Issue 9, 2009, Pages

  McGimpsey, Stuart J ^a   Woodside, Jayne V ^b   Cardwell, Chris ^b   Cahill, Mark ^c   Chakravarthy, Usha ^a,d  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ARTICLE; BLOOD LEVEL; BRANCH RETINAL VEIN OCCLUSION; CASE CONTROL STUDY; CENTRAL RETINA VEIN OCCLUSION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOCYSTEINE BLOOD LEVEL; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; STATISTICAL ANALYSIS;

EID: 69349090928     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.02.033     Document Type: Article

References (82)

1. David R., Zangwill L., Badarna M., and Yassur Y. Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 197 (1988) 69-74
2. Klein R., Wang Q., Klein B.E., et al. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci 36 (1995) 182-191
3. Martin S.C., Butcher A., Martin N., et al. Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86 (2002) 774-776
4. Tsaloumas M.D., Kirwan J., Vinall H., et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 14 (2000) 821-827
5. Hayreh S.S., Zimmerman B., McCarthy M.J., and Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131 (2001) 61-77
6. Deramo V.A., Cox T.A., Syed A.B., et al. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 121 (2003) 1297-1302
7. Cahill M.T., Stinnett S.S., and Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 136 (2003) 1136-1150
8. Clarke R. Commentary: an updated review of the published studies of homocysteine and cardiovascular disease. Int J Epidemiol 31 (2002) 70-71
9. Wald D.S., Wald N.J., Morris J.K., and Law M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333 (2006) 1114-1117
10. McGimpsey S.J., Woodside J.V., Bamford L., et al. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype. Invest Ophthalmol Vis Sci 46 (2005) 4712-4716
11. Atchaneeyasakul L.O., Trinavarat A., Bumrungsuk P., and Wongsawad W. Anticardiolipin IgG antibody and homocysteine as possible risk factors for retinal vascular occlusive disease in Thai patients. Jpn J Ophthalmol 49 (2005) 211-215
12. Pinna A., Carru C., Zinellu A., et al. Plasma homocysteine and cysteine levels in retinal vein occlusion. Invest Ophthalmol Vis Sci 47 (2006) 4067-4071
13. Refsum H., Smith A.D., Ueland P.M., et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50 (2004) 3-32
14. Harmon D.L., Woodside J.V., Yarnell J.W., et al. The common 'thermolabile' variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89 (1996) 571-577
15. Jacques P.F., Bostom A.G., Williams R.R., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
16. Janssen M.C., den Heijer M., Cruysberg J.R., et al. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?. A meta-analysis of thrombophilic factors. Thromb Haemost 93 (2005) 1021-1026
17. Yildirim C., Yaylali V., Tatlipinar S., et al. Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 218 (2004) 102-106
18. Yaghoubi G.H., Madarshahian F., and Mosavi M. Hyperhomocysteinaemia: risk of retinal vascular occlusion. East Mediterr Health J 10 (2004) 633-639
19. Terrazzi P., Di Micco P., Quaglia I., et al. Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion. Thromb J [serial online] 3 (2005) 13. http://www.thrombosisjournal.com/content/3/1/13 Accessed December 17, 2008
20. Lattanzio R., Sampietro F., Ramoni A., et al. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina 26 (2006) 65-70
21. Narayanasamy A., Subramaniam B., Karunakaran C., et al. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci 48 (2007) 1441-1446
22. Moghimi S., Najmi Z., Faghihi H., et al. Hyperhomocysteinemia and central retinal vein occlusion in Iranian population. Int Ophthalmol 28 (2008) 23-28
23. Gao W., Wang Y.S., Zhang P., and Wang H.Y. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population. Graefes Arch Clin Exp Ophthalmol 244 (2006) 1246-1249
24. Gumus K., Kadayifcilar S., Eldem B., et al. Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?. Clin Experiment Ophthalmol 34 (2006) 305-311
25. Woodside J.V., Yarnell J.W., McMaster D., et al. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr 67 (1998) 858-866
26. Ashfield-Watt P.A., Pullin C.H., Whiting J.M., et al. Methylenetetrahydrofolate reductase 677C->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 76 (2002) 180-186
27. Marcucci R., Bertini L., Giusti B., et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 86 (2001) 772-776
28. Marcucci R., Giusti B., Betti I., et al. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 110 (2003) 7-12
29. Hozo S.P., Djulbegovic B., and Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol [serial online] 5 (2005) 13. http://www.biomedcentral.com/1471-2288/5/13 Accessed December 17, 2008
30. Boyd S., Owens D., Gin T., et al. Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion. Br J Ophthalmol 85 (2001) 1313-1315
31. Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1(updated September 2008): Section 7.7.3.5 The Cochrane Collaboration 2008. Available at: http://www.cochrane-handbook.org/. Accessed December 17, 2008.
32. Parodi M.B., and Di Crecchio L. Hyperhomocysteinemia in central retinal vein occlusion in young adults. Semin Ophthalmol 18 (2003) 154-159
33. Whitehead A. Meta-Analysis of Controlled Clinical Trials (2002), Wiley, Chichester, UK 233-235
34. Yanamandra K., Thurmon T.F., Bocchini Jr. J.A., and Kooragayala L.M. Hyperhomocysteinemia and BRVO [letter]. Ophthalmology 110 (2003) 2069 author reply 2069
35. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
36. Gart J.J., and Zweifel J.R. On the bias of various estimators of the logit and its variance with application to quantal bioassay. Biometrika 54 (1967) 181-187
37. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
38. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
39. Duval S., and Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000) 455-463
40. Abu El-Asrar A.M., Abdel Gader A.G., Al-Amro S.A., and Al-Attas O.S. Hyperhomocysteinemia and retinal vascular occlusive disease. Eur J Ophthalmol 12 (2002) 495-500
41. Adamczuk Y.P., Iglesias Varela M.L., Martinuzzo M.E., et al. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13 (2002) 623-626
42. Backhouse O., Parapia L., Mahomed I., and Lee D. Familial thrombophilia and retinal vein occlusion. Eye 14 (2000) 13-17
43. Blondel J., Glacet-Bernard A., Bayani N., et al. Retinal vein occlusion and hyperhomocysteinemia [in French]. J Fr Ophtalmol 26 (2003) 249-253
44. Brown B.A., Marx J.L., Ward T.P., et al. Homocysteine: a risk factor for retinal venous occlusive disease. Ophthalmology 109 (2002) 287-290
45. Cahill M., Karabatzaki M., Meleady R., et al. Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 84 (2000) 154-157
46. Chua B., Kifley A., Wong T.Y., and Mitchell P. Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 139 (2005) 181-182
47. Cruciani F., Moramarco A., Curto T., et al. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Clin Ter 154 (2003) 299-303
48. Di Crecchio L., Parodi M.B., Sanguinetti G., et al. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion. Ophthalmology 111 (2004) 940-945
49. Glueck C.J., Bell H., Vadlamani L., et al. Heritable thrombophilia and hypofibrinolysis: possible causes of retinal vein occlusion. Arch Ophthalmol 117 (1999) 43-49
50. Hansen L., Kristensen H.L., Bek T., and Ingerslev J. Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand 78 (2000) 523-526
51. Lahey J.M., Tunc M., Kearney J., et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 109 (2002) 126-131
52. Larsson J., Hultberg B., and Hillarp A. Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion. Acta Ophthalmol Scand 78 (2000) 340-343
53. Martin S.C., Rauz S., Marr J.E., et al. Plasma total homocysteine and retinal vascular disease. Eye 14 (2000) 590-593
54. Pianka P., Almog Y., Man O., et al. Hyperhomocysteinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion. Ophthalmology 107 (2000) 1588-1592
55. Sottilotta G., Oriana V., Latella C., et al. Role of hyperhomocysteinemia in retinal vascular occlusive disease. Clin Appl Thromb Hemost 13 (2007) 104-107
56. Stanger O., Weger M., Obeid R., et al. Impairment of homocysteine metabolism in patients with retinal vascular occlusion and non-arteritic ischemic optic neuropathy. Clin Chem Lab Med 43 (2005) 1020-1025
57. Vine A.K. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 98 (2000) 493-503
58. Vine A.K. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion. Am J Ophthalmol 129 (2000) 640-644
59. Weger M., Stanger O., Deutschmann H., et al. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 109 (2002) 1105-1109
60. Weger M., Stanger O., Deutschmann H., et al. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240 (2002) 286-290
61. Lahey J.M., Kearney J.J., and Tunc M. Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9 (2003) 385-392
62. Battaglia Parodi M., and Di Crecchio L. Hyperhomocysteinemia and retinal vascular occlusive disease [letter]. Eur J Ophthalmol 13 (2003) 500 author reply 500-1
63. Weger M., Stanger O., and Haas A. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion [letter]. Am J Ophthalmol 131 (2001) 290-291
64. Biousse V., Newman N.J., and Sternberg Jr. P. Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. Am J Ophthalmol 124 (1997) 257-260
65. Cabezas-Leon M.M., Garcia-Montero M.R., and Morente-Matas P. Hyperhomocysteinemia as a risk factor for central retinal vein thrombosis in a young patient [in Spanish]. Rev Neurol 37 (2003) 441-443
66. Hartnett M.E., Laposata M., and Van Cott E. Antiphospholipid antibody syndrome in a six-year-old female patient. Am J Ophthalmol 135 (2003) 542-544
67. Ozdek S., Yulek F., Gurelik G., et al. Simultaneous central retinal vein and retinal artery branch occlusions in two patients with homocystinaemia [letter]. Eye 18 (2004) 942-945
68. Palmowski A.M., Geisel J., Herrmann W., et al. Venous thromboembolism in a young patient. Diagnosis: Retinal vein thromboembolism in mutation of the methylenetetrahydrofolate reductase gene [in German]. Ophthalmologe 96 (1999) 618-619
69. Wenzler E.M., Rademakers A.J., Boers G.H., et al. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115 (1993) 162-167
70. Cahill M., Karabatzaki M., Donoghue C., et al. Thermolabile MTHFR genotype and retinal vascular occlusive disease. Br J Ophthalmol 85 (2001) 88-90
71. Dodson P.M., Haynes J., Starczynski J., et al. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion. Eye 17 (2003) 772-777
72. Gao W., Wang Y.S., Zhang P., and Wang H.Y. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population. Thromb Res 121 (2008) 699-703
73. Loewenstein A., Goldstein M., Winder A., et al. Retinal vein occlusion associated with methylenetetrahydrofolate reductase mutation. Ophthalmology 106 (1999) 1817-1820
74. Salomon O., Moisseiev J., Rosenberg N., et al. Analysis of genetic polymorphisms related to thrombosis and other risk factors in patients with retinal vein occlusion. Blood Coagul Fibrinolysis 9 (1998) 617-622
75. Duic J., and Gveric-Krecak V. Recurrent incomplete central retinal vein occlusion in a patient with hereditary thrombophilia [in Croatian]. Acta Med Croatica 60 (2006) 171-174
76. Loewenstein A., Winder A., Goldstein M., et al. Bilateral retinal vein occlusion associated with 5,10-methylenetetrahydrofolate reductase mutation. Am J Ophthalmol 124 (1997) 840-841
77. Chak M., Wallace G.R., Graham E.M., and Stanford M.R. Thrombophilia: genetic polymorphisms and their association with retinal vascular occlusive disease. Br J Ophthalmol 85 (2001) 883-886
78. Lewis S.J., Ebrahim S., and Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate [online report]?. BMJ 331 (2005) 1053. http://www.bmj.com/cgi/content/full/331/7524/1053 Accessed December 17, 2008
79. Broekmans W.M., Klopping-Ketelaars I.A., Schuurman C.R., et al. Fruits and vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J Nutr 130 (2000) 1578-1583
80. Samman S., Sivarajah G., Man J.C., et al. A mixed fruit and vegetable concentrate increases plasma antioxidant vitamins and folate and lowers plasma homocysteine in men. J Nutr 133 (2003) 2188-2193
81. Davey Smith G., and Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 32 (2003) 1-22
82. Stroup D.F., Berlin J.A., Morton S.C., et al., Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283 (2000) 2008-2012